---
title: "Research Alert: CFRA Keeps Buy Opinion On Shares Of Antero Resources Corporation"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285604195.md"
description: "CFRA maintains a Buy opinion on Antero Resources Corporation, setting a 12-month target of $48 based on a 6x enterprise value to EBITDA multiple. They raised 2026 EPS estimates to $4.37 and 2027 to $4.90. Antero is seen as a low-cost natural gas provider with a strong NGL exposure. The company has improved its net debt-to-EBITDA ratio to 2.1x, enhancing financial flexibility. Despite trading at a discount to historical averages, earnings are expected to improve significantly."
datetime: "2026-05-07T19:30:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285604195.md)
  - [en](https://longbridge.com/en/news/285604195.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285604195.md)
---

# Research Alert: CFRA Keeps Buy Opinion On Shares Of Antero Resources Corporation

03:30 PM EDT, 05/07/2026 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

Our 12-month target remains $48, a 6x multiple of enterprise value to our 2027 EBITDA estimate, in line with AR's historical forward average. We raise our 2026 EPS estimate by $1.11 to $4.37 and our 2027 EPS estimate by $0.76 to $4.90. We see AR as a leading provider of relatively low-cost natural gas, as well as a healthy degree of NGL exposure. Management is 45% hedged in 2026 in the $3.90/MMBtu range, but that hedge protection drops to about the 30% range for 2027. Following the pending Ohio Utica divestiture, and the now-completed HG deal, AR's exposure to the Marcellus only rises. We see the Marcellus as a relatively lower-cost gas play. AR ended 2025 with a net debt-to-EBITDA ratio of just 2.1x, down from 4.9x at the end of 2024, and yielding considerably improved financial flexibility in our view. We estimate that shares are trading at a sizable discount to AR's historical forward average, despite our view that earnings power should improve to nearly 2022-era levels.

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

### Related Stocks

- [AR.US](https://longbridge.com/en/quote/AR.US.md)

## Related News & Research

- [Antero Resources (NYSE:AR) Insider Sells $1,550,772.30 in Stock](https://longbridge.com/en/news/285349461.md)
- [UK REEVES REFORMS TAX ON FOREIGN OIL AND GAS FIRMS](https://longbridge.com/en/news/287213345.md)
- [Research Alert: CFRA Keeps Sell Opinion On Shares Of Ovintiv Inc.](https://longbridge.com/en/news/286726789.md)
- [Guardant Health Says US FDA Approved Liquid Biopsy Test](https://longbridge.com/en/news/287069625.md)
- [FDA Approves New Guardant360 Liquid CDx, the Largest FDA-Approved Liquid Biopsy Panel with a 100x Expanded Footprint | GH Stock News](https://longbridge.com/en/news/287061152.md)